WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H341522
CAS#: 41806-51-3
Description: W10294A is a biochemical.
Hodoodo Cat#: H341522
Name: W10294A
CAS#: 41806-51-3
Chemical Formula: C21H30Cl2N2O4
Exact Mass: 444.16
Molecular Weight: 445.381
Elemental Analysis: C, 56.63; H, 6.79; Cl, 15.92; N, 6.29; O, 14.37
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: W10294A; W 10294A; W-10294A; NSC 305338.
IUPAC/Chemical Name: 5H-(1)Benzopyrano(3,4-c)pyridin-5-one, 1,2,3,4-tetrahydro-8,9-dimethoxy-3-(2-(1-piperidinyl)ethyl)-, dihydrochloride
InChi Key: XALXYYFPCSMBBL-UHFFFAOYSA-N
InChi Code: InChI=1S/C21H28N2O4.2ClH/c1-25-19-12-16-15-6-9-23(11-10-22-7-4-3-5-8-22)14-17(15)21(24)27-18(16)13-20(19)26-2;;/h12-13H,3-11,14H2,1-2H3;2*1H
SMILES Code: O=C1OC2=CC(OC)=C(OC)C=C2C3=C1CN(CCN4CCCCC4)CC3.[H]Cl.[H]Cl
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 445.38 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Tröger A, Siepermann M, Mahotka C, Wethkamp N, Bülle H, Laws HJ, Escherich G, Janka-Schaub G, Göbel U, Dilloo D. Role of survivin splice variants in pediatric acute precursor B lymphoblastic leukemia. Klin Padiatr. 2007 May-Jun;219(3):127-33. PubMed PMID: 17525905.
2: Van Berkum JJ, Koornneef AW, Otten M, Nieuwland MS. Establishing reference in language comprehension: an electrophysiological perspective. Brain Res. 2007 May 18;1146:158-71. Epub 2006 Aug 17. PubMed PMID: 16916496.
3: Littner MR, Schachter EN, Bouhuys A. Modification of induced airway constriction in healthy subjects. Ann Allergy. 1979 Sep;43(3):135-43. PubMed PMID: 475062.
4: Littner MR. W10294A: a new bronchodilator. Lung. 1977;154(3):187-94. PubMed PMID: 916727.